Effectiveness of novel combination chemotherapy, consisting of Temozolomide, Bevacizumab and Irinotecan as salvage chemotherapy regimen in the treatment of primary pediatric brain tumors
Soheila Zareifar M.D1, Mehrpour Moradi M.D1, Mehran Karimi M.D1, Amirhossein Najibi2, Mehrnaz Moradi2
  1. Hematology research center, Shiraz university of medical sciences, Shiraz, Iran
  2. Student research committee, Fasa university of medical sciences, Fasa, Iran
*Correspondence to:
Mehrpour Moradi, MD, Hematology research center, Shiraz university of medical sciences, Shiraz, Iran, Tel.:0989173413740, Email: moradime@yahoo.com
Text word count: 3020
Abstract word count: 246
Brief running title: Irinotecan therapy in pediatric brain tumors
Keywords: children, brain tumor, combination chemotherapy, Irinotecan
Tables: 6
Figures: 2